JP2003535965A - インフルエンザウイルス結合性シアル化オリゴ糖含有物質およびその用途 - Google Patents

インフルエンザウイルス結合性シアル化オリゴ糖含有物質およびその用途

Info

Publication number
JP2003535965A
JP2003535965A JP2002503303A JP2002503303A JP2003535965A JP 2003535965 A JP2003535965 A JP 2003535965A JP 2002503303 A JP2002503303 A JP 2002503303A JP 2002503303 A JP2002503303 A JP 2002503303A JP 2003535965 A JP2003535965 A JP 2003535965A
Authority
JP
Japan
Prior art keywords
neunac
linked
terminal
bond
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002503303A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003535965A5 (enExample
Inventor
ミレル−ポドラサ，ハリナ
カールソン，カール−アンデシュ
Original Assignee
バイオティ セラピィーズ コープ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオティ セラピィーズ コープ filed Critical バイオティ セラピィーズ コープ
Publication of JP2003535965A publication Critical patent/JP2003535965A/ja
Publication of JP2003535965A5 publication Critical patent/JP2003535965A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2002503303A 2000-06-21 2001-06-20 インフルエンザウイルス結合性シアル化オリゴ糖含有物質およびその用途 Pending JP2003535965A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20001477A FI20001477A7 (fi) 2000-06-21 2000-06-21 Influenssavirusta sitova aine ja sen käyttö
FI20001477 2000-06-21
PCT/FI2001/000587 WO2001097819A1 (en) 2000-06-21 2001-06-20 Influenza virus binding, sialylated oligosaccharide substance and use thereof

Publications (2)

Publication Number Publication Date
JP2003535965A true JP2003535965A (ja) 2003-12-02
JP2003535965A5 JP2003535965A5 (enExample) 2008-07-31

Family

ID=8558611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002503303A Pending JP2003535965A (ja) 2000-06-21 2001-06-20 インフルエンザウイルス結合性シアル化オリゴ糖含有物質およびその用途

Country Status (6)

Country Link
US (1) US7902170B2 (enExample)
EP (1) EP1320374A1 (enExample)
JP (1) JP2003535965A (enExample)
AU (1) AU7257101A (enExample)
FI (1) FI20001477A7 (enExample)
WO (1) WO2001097819A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7619136B2 (en) 2005-04-05 2009-11-17 National Institute Of Advanced Industrial Science And Technology Technique for extending biological sugar chain via introduction of glycosyltransferase gene
US7943820B2 (en) 2004-08-31 2011-05-17 National Institute Of Advanced Industrial Science And Technology Genetically modified plants producing lactosylceramide and utilization thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20031536A0 (fi) * 2003-10-20 2003-10-20 Biotie Therapies Oyj Korkean affiniteetin ligandit influenssavirukselle ja menetelmät niiden valmistamiseen
FI20060200A0 (fi) * 2005-04-20 2006-02-27 Glykos Finland Oy Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi
WO2007026669A1 (ja) * 2005-09-02 2007-03-08 Shizuoka Prefectural Universities Corporation ウイルスレセプター糖鎖認識特異性の判別方法
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
US20250302865A1 (en) * 2022-03-16 2025-10-02 Pharmalectin, Inc. Lectin-binding carbohydrates for treating viral infections

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5101026A (en) * 1986-08-06 1992-03-31 Mect Corporation Ganglioside related compounds and method of producing the same
US5220008A (en) * 1991-11-22 1993-06-15 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
US5254676A (en) * 1991-11-22 1993-10-19 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
WO1998003524A1 (fr) * 1996-07-23 1998-01-29 Seikagaku Corporation Nouveaux oligosaccharides a base de lactosamine et procede de preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5101026A (en) * 1986-08-06 1992-03-31 Mect Corporation Ganglioside related compounds and method of producing the same
US5220008A (en) * 1991-11-22 1993-06-15 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
US5254676A (en) * 1991-11-22 1993-10-19 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
WO1998003524A1 (fr) * 1996-07-23 1998-01-29 Seikagaku Corporation Nouveaux oligosaccharides a base de lactosamine et procede de preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943820B2 (en) 2004-08-31 2011-05-17 National Institute Of Advanced Industrial Science And Technology Genetically modified plants producing lactosylceramide and utilization thereof
US7619136B2 (en) 2005-04-05 2009-11-17 National Institute Of Advanced Industrial Science And Technology Technique for extending biological sugar chain via introduction of glycosyltransferase gene

Also Published As

Publication number Publication date
US7902170B2 (en) 2011-03-08
FI20001477L (fi) 2001-12-22
FI20001477A7 (fi) 2001-12-22
FI20001477A0 (fi) 2000-06-21
AU7257101A (en) 2002-01-02
WO2001097819A1 (en) 2001-12-27
US20030181714A1 (en) 2003-09-25
EP1320374A1 (en) 2003-06-25

Similar Documents

Publication Publication Date Title
US4980462A (en) Antiviral agents
Hakomori Glycosphingolipids having blood-group ABH and Lewis specificities
US20080112955A1 (en) Method and composition for preventing pain in sickle cell patients
CZ341097A3 (cs) Sulfatované oligosacharidy, způsob jejich výroby a použití
RU2283115C2 (ru) Новые вещества, связывающиеся с helicobacter pylori, и их применение
RU2306140C2 (ru) НОВЫЕ РЕЦЕПТОРЫ ДЛЯ Helicobacter pylori И ИХ ПРИМЕНЕНИЕ
JPH04502153A (ja) マイコプラズマ　ニューモニエ及びマイコプラズマホミヌスのスルファチドへの接着
US20060122148A1 (en) High affinity receptors for helicobacter pylori and use thereof
JPH10504529A (ja) 肺細胞及び血管細胞への肺炎球菌粘着のモジュレーター並びに診断及び治療上の適用
JP2003535965A (ja) インフルエンザウイルス結合性シアル化オリゴ糖含有物質およびその用途
EP1169044B1 (en) Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
EP1476454A1 (en) Binding epitopes for helicobacter pylori and use thereof
JP2838147B2 (ja) ネオ糖タンパク質およびその製法
Miller-Podraza et al. Studies on gangliosides with affinity for Helicobacter pylori: binding to natural and chemically modified structures
Miller-Podraza et al. Helicobacter pylori binding to new glycans based on N-acetyllactosamine
JP2007308444A (ja) シアル酸含有糖鎖複合体及びその製造方法、並びに、該シアル酸含有糖鎖複合体を含有する抗インフルエンザウイルス剤
CA2253913A1 (en) Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
Müthing Glycobiology Advance Access published April 25, 2012
Miller-Podraza Different glycosphingolipid composition in human neutrophil subcellular compartments
CELL Biochemical Studies on Hairy Cell Leukemic Cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080612

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080612

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110912

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111201

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120502